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Yersinia enterocolitica is an invasive enteric pathogen that causes significant inflammatory disease. Recently,
we identified and characterized a global regulator of virulence (rovA). When mice are infected orally with the
rovA mutant they are attenuated by 50% lethal dose (LD50) analysis and have altered kinetics of infection. Most
significantly, mice orally infected with the rovA mutant have greatly reduced inflammation in the Peyer’s
patches compared to those infected with wild-type Y. enterocolitica. However, we present data here indicating
that when the rovA mutant bacteria are delivered intraperitoneally (i.p.), they are significantly more virulent
than when delivered orally. The i.p. LD50 for the rovA mutant is only 10-fold higher than that of the wild-type
Y. enterocolitica, and there are significant inflammatory responses to the rovA mutant that are evident in the
liver and spleen. Altogether, these data suggest that the RovA regulon may be required for the early events of
the infection that occur in the Peyer’s patches. Furthermore, these data suggest that the RovA regulon may be
dispensable for Y. enterocolitica systemic disease and inflammatory responses if the Peyer’s patches are
bypassed.
Yersinia enterocolitica is one of three species of Yersinia that
are pathogenic for humans (7). The other two pathogenic
species of Yersinia are Yersinia pseudotuberculosis and Yersinia
pestis. Both Y. enterocolitica and Y. pseudotuberculosis are en-
teric pathogens, whereas Y. pestis is the causative agent of
plague. Y. enterocolitica infection is usually the result of con-
suming contaminated food or water and usually results in a
self-limiting infection that presents as gastroenteritis and/or
lymphadenitis (26).
The initial site of Y. enterocolitica infection is the secondary
lymphoid tissues of the small intestine called Peyer’s patches
(PP). To gain entry to the PP, the bacteria must first bind to
and then cross the specialized intestinal epithelium (M cells)
that overlay the PP. The binding and translocation event is
mediated by the bacterial invasin protein (Inv) (14, 18). Inv is
an outer membrane protein that binds to 1-integrins ex-
pressed on the apical surface of the M cell (9, 13, 15). Inv is
required for the efficient translocation of the bacteria across
the intestinal epithelium (22). In fact, when an inv mutant is
examined in the mouse model of infection it has an altered
pathogenesis phenotype compared to the wild-type (WT) bac-
teria (22). Interestingly, even though there is a delay in the
colonization of the PP of mice infected with the inv mutant,
there is no difference in the 50% lethal dose (LD50) (22).
When the expression characteristics of the Inv protein were
examined in vitro it was found that expression was modulated
by environmental factors such as temperature, pH, and growth
phase (21). These data suggested that there was a regulator of
Inv expression. Recently, we identified the Inv regulator and
named it RovA (24). A homologue of RovA has been identi-
fied in Y. pseudotuberculosis and was shown to regulate the
expression of inv in that organism as well (20). RovA is a
member of the MarR family of transcriptional regulators and
is responsible for the regulation of Inv expression both in vitro
and in vivo (24). Subsequent analysis of the rovA mutant in the
mouse provided several lines of evidence that suggested RovA
plays a key role in the pathogenesis of a Y. enterocolitica in-
fection. First, a rovA mutant is attenuated by LD50 analysis in
BALB/cj mice and shows altered kinetics of infection in this
mouse (24). Second, a rovA mutant is deficient in the initiation
of inflammation in the PP, a phenotype that is not a conse-
quence of the decreased levels of Inv observed in the rovA
mutant. Further analysis of the rovA mutant in vivo suggested
that the defect in the initiation of PP inflammation was linked
to a defect in the ability of the host to produce interleukin-1
(IL-1) in response to bacterial infection (12). Altogether,
these data suggested that RovA was playing a central role in
the infectious process that included the regulation of Inv and
other as-yet-undetermined gene products. One or more of
these unidentified genes are most likely responsible for the
inflammatory pathologies observed during a Y. enterocolitica
infection.
When the phenotypes of both the inv and the rovA mutant
were considered together, it was reasonable to assume that
RovA was important for the regulation of genes that influence
the early stages of infection that occur in the PP. Therefore, it
was of interest to reexamine the phenotype of the rovA mutant
in vivo when the natural route of infection is bypassed. In this
report we provide data suggesting that RovA is less critical for
virulence in the mouse model when the bacteria are delivered
by the intraperitoneal (i.p.) route of infection. Furthermore,
when mice are infected i.p. with the rovA mutant they are
* Corresponding author. Mailing address: Washington University
School of Medicine, Department of Molecular Microbiology, 660 S.
Euclid Ave., Campus Box 8230, St. Louis, MO 63110. Phone: (314)
286-2891. Fax: (314) 286-2896. E-mail: virginia@borcim.wustl.edu.
† Present address: Department of Pathology and Immunology,




 January 16, 2014 by W







capable of mounting a significant inflammatory response that is
not observed during oral infection.
MATERIALS AND METHODS
Mice. Female C57BL/6J mice 6 to 8 weeks of age were purchased from
Jackson Laboratory and maintained in the barrier facility at Washington Uni-
versity School of Medicine. Mice were given free access to food and water
throughout all experiments. Animals were sacrificed by carbon dioxide asphyxi-
ation. The Washington University committee on animal studies approved all
animal experiments.
Bacteria. Y. enterocolitica strains used in the present study are WT strain
(JB580v) (16) and the rovA mutant (YVM641) (22). Both strains are derivatives
of the serogroup O8 strain 8081 and carry the pYV virulence plasmid. For
inoculation of the mice, bacteria were grown overnight in Luria-Bertani (LB)
broth at 26°C. Actual numbers of CFU were determined by serial dilutions of the
overnight culture, followed by plating on LB agar containing 20 g of nalidixic
acid/ml; both JB580v and YVM641 are resistant to nalidixic acid.
LD50 and kinetics analysis. Five groups of five mice were infected orally by
gavage with successive 10-fold dilutions of the bacterial suspension (104 to 109
bacteria) or i.p. with 10 to 106 bacteria for WT or 102 to 107 bacteria for the rovA
mutant. The mice were monitored twice daily for 14 days. This analysis was done
in duplicate in two independent experiments. The LD50 values were determined
according to the method of Reed and Muench (23). Kinetic analysis was done by
infecting mice i.p. with the indicated dose of the WT Y. enterocolitica strain
JB580v (16) or the rovA mutant YVM641. At various times postinfection (1, 3,
or 5 days), mice from each group were sacrificed and tissues (PP, mesenteric
lymph nodes, spleen, and liver) were removed. The bacterial load recovered from
the infected organs was determined by plating dilutions of the macerated tissues
onto LB plates containing 20 g of nalidixic acid/ml to select for Yersinia and was
reported as the CFU per gram of tissue. This kinetics analysis was done in
duplicate in two independent experiments.
Histopathology. Mice of the specified group were infected i.p. with indicated
amounts of WT Y. enterocolitica strain JB580v or rovA mutant YVM641. On days
1, 3, 5, 14, and 24 postinfection the mice were sacrificed and the small intestines,
mesenteric lymph nodes, spleen, liver, kidney, and lungs were removed. The
lumen of the intestine was flushed with phosphate-buffered saline (PBS), and
then tissues were fixed in either 10% neutral buffered formaldehyde or Bouin’s
fixative prior to being embedded in paraffin and stained with hematoxylin and
eosin. Mice infected orally by gavage for 14 or 24 days were treated in a similar
manner. Slides were investigated in a blind fashion by two independent investi-
gators. Tissue sections were given an arbitrary score based on the frequency and
severity of the lesions. Tissues were scored on a scale of 0 to 4, with 0 repre-
senting no histopathologic abnormality (consistent with the mock-infected con-
trol tissues) and 4 being the most severe pathology observed. Sections were
scored for increased numbers of macrophages and neutrophils, granuloma for-
mation, inflammatory infiltrates, necrosis, fibrin thrombi, bacterial colonization,
and adhesions. A minimum of five mice per time point were examined. Tissues
from dead mice were excluded from analysis.
Immunohistochemistry of paraffin-embedded sections. Detection of Y. entero-
colitica within the tissues of infected mice was performed by using the avidin-
biotin complex procedure as described previously (19). Y. enterocolitica was
detected by using purified rabbit polyclonal antibodies directed against mem-
branes from the WT strain (JB580v) at a dilution of (1:500). Antibodies were
prepared by the immunization of a New Zealand White rabbit with Y. enteroco-
litica membrane preparations. After exsanguination, serum was separated from
whole blood. Serum was absorbed with acetone powders derived from E. coli
strains DH5 and HB101 and Salmonella enterica serovar Typhimurium strain
14028s. Immunoglobulin G was then purified from the absorbed serum by affinity
chromatography by using protein A-Sepharose. Positive staining was detected by
using diaminobenzidine, and sections were counterstained with Mayer’s hema-
toxylin.
Immunohistochemistry of frozen sections. Mice were infected i.p. with 103
CFU of WT or rovA mutant bacteria and then sacrificed after 14 or 24 days, and
the indicated tissues were removed, embedded in OCT compound, and flash
frozen. Sections were cut on a cryostat and fixed in acetone or methanol prior to
staining. Tissues were rehydrated in PBS. Peroxidase activity was blocked by
incubation with 0.3% hydrogen peroxide and then blocked with bovine serum
albumin and milk, as well as avidin-biotin block (Vector Laboratories). Sections
were incubated overnight with biotinylated antibody at the indicated concentra-
tions. The antibodies used were anti-murine macrophage antigen F4/80 (1:250;
Serotec), anti-TCR (1:1,000; Pharmingen), and anti-Y. enterocolitica (1:1,000).
Granulocytes were detected with anti-GR-1 antigen (1:250; Pharmingen). Sec-
tions were washed in PBS and then incubated with 1 g of streptavidin-horse-
radish peroxidase and goat anti-rabbit-fluorescein isothiocyanate (1:1,000)/ml for
1 h. Sections were washed in PBS, and then positive staining was detected by
using tyramide signal amplification 3 cyanine (Dupont-NEN) counterstained
with Hoechst stain and visualized with fluorescence microscopy.
Statistical analysis. All statistical analysis was done by using GraphPad Prism
v.3.03 (Graphpad Software). Kinetic data was log10 transformed and then sub-
jected to analysis of variance by using a nonparametric Mann-Whitney test to
generate a two-tailed P value. Comparisons were made between a given tissue
within a given time point. Statistically significant comparisons are denoted with
an asterisk.
RESULTS
The rovA mutant is more virulent by the i.p. route of infec-
tion than by the oral route. The normal route of infection for
Y. enterocolitica is via the oral route. Previously, we reported
that when BALB/cj mice were orally infected with the rovA
mutant they were found to be 70-fold attenuated by LD50
analysis compared to the WT bacteria (24). When the oral
LD50 was determined for the rovA mutant in C57BL/6j mice,
the bacteria were even less virulent in this mouse background.
In the C57BL/6j background the rovA mutant was 500-fold
attenuated compared to the WT bacteria in an oral LD50
analysis (Fig. 1A). Interestingly, when this analysis was ex-
tended to include the i.p. route of infection the rovA mutant
was almost as virulent as the WT bacteria, with only an 11-fold
change in LD50, (Fig. 1A). These data suggest that rovA may
play a more important role in the establishment of colonization
of the PP and/or dissemination from the PP than in the elab-
oration of a systemic infection.
When the kinetics of oral infection were examined for the
rovA mutant in the BALB/cj mouse model, it was apparent that
there was a defect in the ability of the rovA mutant to dissem-
inate (24). The BALB/cj mice infected orally with the rovA
mutant showed a defect in the dissemination to the mesenteric
lymph nodes and, to a lesser extent, the spleen compared to
mice infected with WT bacteria. C57BL/6j mice infected orally
with the WT bacteria or the rovA mutant showed a similar but
more pronounced dissemination defect than that observed
with oral infection of BALB/cj mice (data not shown). Analysis
of an i.p. rovA infection of C57BL/6j mice displayed a different
kinetic profile than that for the oral infection (Fig. 1B). There
was significant colonization of all of the tissues by day 1 when
the mice were infected with the WT bacteria. However, when
the mice were infected i.p. with the rovA mutant there were
fewer bacteria colonizing the deeper tissues at earlier time
points (especially days 1 and 3) compared to the WT. Unlike
the data from the oral infection studies, there appears to be no
bias in the colonization of the deeper tissues by the rovA
mutant (i.e., all tissues are equally affected) nor does there
appear to be a significant virulence defect once infection is
established. There only appears to be a delay in efficient col-
onization. Statistical analysis suggests that there were no sig-
nificant differences between mice infected i.p. with WT bacte-
ria and mice infected with the rovA mutant. When subjected to
statistical analysis, only the data from spleens infected for 5
days were statistically significant (P  0.0055). Altogether,
these data, considered along with the LD50 data, suggest that
RovA may be required early in i.p. infection but then, as the
infectious process proceeds, the rovA mutant behaves more
like the WT bacteria.
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Histopathology of i.p. infection with either WT Y. enteroco-
litica or rovA mutant reveals inflammatory changes. The most
striking phenotype of an oral infection with the rovA mutant is
a lack of PP inflammation due to decreased levels of IL-1
(12); this is in contrast to infection with WT Y. enterocolitica,
which shows extensive inflammation as early as 2 days postin-
fection. The initial studies only examined a 7-day time course
of infection. To further study the inflammatory response to the
rovA mutant, an analysis of the tissues after an extended oral
infection was conducted. C57BL/6j mice were infected orally
with either rovA mutant or WT Y. enterocolitica for 14 or 24
days. Tissues (small intestine, spleen, liver, kidney, and mes-
enteric lymph nodes) were removed and prepared for hema-
toxylin and eosin staining, followed by histological examina-
tion. Histopathology data are summarized in Tables 1 and 2.
The histopathology of earlier time points of Y. enterocolitica
infection has been described (2, 6, 12). Interestingly, as previ-
ously reported for earlier time points, mice infected orally with
the rovA mutant did not have a strong inflammatory response
even at the 24-day time point in any of the tissues. However, an
acute inflammatory response to infection with WT Y. entero-
colitica was apparent by day 3 in the PP and mesenteric lymph
nodes and in all tissues examined by day 7 (12). The mice
infected orally with the WT Y. enterocolitica for 14 days had
more severe inflammatory pathologies than the mice infected
orally for 24 days. This is probably due to the mice with the
most severe pathologies dying prior to the 24-day time point.
To further examine the inflammatory response to the rovA
mutant, an analysis of the inflammatory response to an i.p.
infection was conducted. C57BL/6j mice were infected i.p. with
either the rovA mutant or WT Y. enterocolitica for 1, 3, 5, 14, or
24 days, and then tissues (small intestine, spleen, liver, lung,
kidney, and mesenteric lymph nodes) were removed and pre-
pared for hematoxylin and eosin staining, followed by histo-
logical examination. Consistent with the kinetic data, there
appeared to be a slight delay in histopathological evidence of
infection by the rovA mutant compared to WT Y. enterocolitica
(Tables 1 and 2). This was readily apparent during gross ex-
amination of the animals during necroscopy. The animals in-
fected with WT Y. enterocolitica developed colonization of the
serosal surfaces of the peritoneum as early as day 1, whereas
the rovA mutant did not show this phenotype until day 3 or
later (data not shown). This same phenotype was evident dur-
ing histological examination of intestinal sections (Fig. 2). Dis-
tinct microcolonies were evident on the serosal surface of the
small intestine (Fig. 2B); this was not observed during an oral
infection. The presence of Y. enterocolitica in the tissues was
confirmed by using a Y. enterocolitica specific antibody (Fig.
2C).
Although there appeared to be an initial delay in the colo-
nization of the peritoneal organs and the onset of inflamma-
tory responses when mice were infected i.p. with the rovA
mutant, severe inflammatory pathologies were evident at the
14- and 24-day time points. This finding is in contrast to an oral
infection with the rovA mutant that showed no significant in-
flammatory response even at 24 days (data not shown). The
most severe pathologies involved the liver. There were multi-
ple liver abscesses in the 24-day rovA mutant i.p.-infected
mouse. Within the liver, lesions included well-defined granu-
lomas (Fig. 2I and Fig. 3), areas of necrosis (Fig. 2F), and
FIG. 1. Analysis of the rovA mutant by the i.p. route of infection.
(A) Five C57BL/6j mice per group were infected orally or i.p. with
10-fold serial dilutions of WT virulent Y. enterocolitica (JB580v) or
rovA mutant (YVM641) and then monitored for death over a 14-day
period. The LD50 was calculated by the method of Reed and Muench
(21). The results are the average of two independent experiments.
(B) Kinetics of infection. C57BL/6j mice were infected i.p. with 105
CFU of WT Y. enterocolitica or rovA mutant. The infection was allowed
to proceed for the indicated amount of time. Mice were then sacrificed,
and the indicated organs were harvested. Bacterial load was deter-
mined by enumerating the number of viable bacteria in each organ (P,
PP; M, mesenteric lymph nodes; S, spleen; L, liver). Each individual
symbol on the histogram represents an individual mouse. Symbols on
the x axis represent tissues that did not have recoverable CFU. The
results are the composite of two independent experiments. Asterisks
indicate statistically significant comparisons (P  0.0055). Eight mice
were analyzed for days 1 and 3. Thirteen mice were analyzed on day 5.
Solid symbols represent the WT Y. enterocolitica-infected animals, and
the open symbols represent mice infected with the rovA mutant. At day
5 (the bottom panel), three of the animals for the WT day 5 time point
died prior to analysis.
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infiltrates of polymorphonuclear leukocytes (PMNs) (Fig. 2E).
The liver lesions often had microabscesses (defined infiltrates
without evidence of bacterial colonization) (Fig. 2F), as well as
microcolonies (defined infiltrates with evidence of bacterial
colonization) (Fig. 2G and H). Adhesions between the liver
and the kidney or the liver and the lung were frequently ob-
served (Fig. 2I). In both cases, normal tissue architecture was
severely disrupted. Inflammatory pathologies were also evident
in other tissues as well, including granulomas of the inguinal
lymph nodes, fimbrin thrombi, ischemic necrosis in the kidneys
and liver, and consolidation of the lungs, as well as edema and
increased macrophages observed in the PP (data not shown).
Interestingly, when the localization of the Yersinia was
examined at later time points (14 or 24 days) by immuno-
histochemistry, the bacteria were almost exclusively con-
tained within the granulomas (Fig. 3). This suggests that
granuloma formation may provide the host partial protec-
tion during a Yersinia infection. Furthermore, these pathol-
ogies were often present in mice that received relatively low
inocula (103 CFU i.p.) of either WT bacteria or rovA mu-
tant. The architecture of granulomas formed in response to
Y. enterocolitica infection is consistent with other types of
granulomas. The center of the granuloma contains bacteria,
PMNs (confirmed by positive GR-1 staining), and cellular
debris (Fig. 3C). A concentric layer of epithelioid macro-
phages detected by F4/80 antigen staining and T cells de-
tected by staining of the  chain of the T-cell receptor
surrounds the center of the granuloma (Fig. 3A and B).
Formation of granulomas in the mice infected i.p. with the
rovA mutant was especially significant because it is indica-
TABLE 1. Histopathology of rovA mutant-infected mice
Source
Avg pathological score (frequency [%]) of mice infected with rovA mutant:
Orally at (day, dose
[CFU], no. of mice): i.p. at (day, dose [CFU], no. of mice):
14, 109, 5 24, 109, 10 1, 105, 5 3, 105, 5 5, 105, 5 14, 104, 8
24
103, 3 104, 3 105, 1 106, 4 107, 2 108, 2
Liver
Granuloma 0 0 0 0 0 4 (0.5) 4 (1) 3 (1) *e 4 (0.5) 0 4 (0.5)
Microcolonya 0 0 3 (0.2) 3 (0.4) 4 (0.4) 3.6 (0.75) 4 (1) 0 * 4 (0.5) 0 3.5 (1)
Microabscessb 0 0 3 (0.2) 3 (0.4) 4 (0.4) 3.6 (0.75) 3.6 (1) 0 * 4 (0.5) 0 3.5 (1)
Necrosis 3 (0.2) 0 0 0 0 3.6 (0.75) 3.3 (1) 3 (1) * 4 (0.5) 0 3.5 (1)
Infiltratec 3 (0.2) 0 2 (0.2) 2.5 (0.4) 4 (0.4) 3.5 (0.1) 4 (0.7) 4 (1) * 2.8 (1) 1 (1) 4 (0.5)
Fibrin thrombi 3 (0.2) 0 0 3 (0.4) 0 0 3 (0.7) 0 * 4 (0.5) 0 3 (0.5)
Adhesion 0 0 0 0 0 4 (0.5) 3.5 (0.7) 0 * 4 (0.5) 0 0
Spleen
Splenomegaly 0 0 0 0 0 2.8 (0.1) 2.5 (1) 0 * 3 (0.5) 0 3.5 (1)
Granuloma 0 0 0 0 0 0 0 0 * 0 0 0
Microcolony 0 0 3 (0.2) 3.5 (0.4) 0 0 0 0 * 0 0 0
Microabscess 0 0 0 0 0 0 0 0 * 0 0 0
Necrosis 0 0 0 2 (0.4) 0 3 (0.3) 2 (0.3) 0 * 0 0 0
Infiltrate 0 0 2 (0.2) 2 (0.2) 0 0 0 0 * 0 0 0
Fibrin thrombi 0 0 0 0 0 0 0 0 * 0 0 0
Adhesion 0 0 0 0 0 0 0 0 * 0 0 0
Inflammationd 0 0 0 2.5 (0.6) 0 2.8 (0.75) 0 0 * 3 (0.5) 0 4 (1)
Mesenteric lymph nodes
Granuloma 0 0 0 0 0 3.8 (1) 4 (0.3) 0 * 4 (1) 0 0
Microcolony 0 0 0 2.5 (0.6) 0 3.8 (1) 4 (0.3) 0 * 3.5 (1) 0 0
Microabscess 0 0 0 3 (0.2) 0 3.8 (1) 4 (0.3) 0 * 4 (1) 0 0
Necrosis 0 0 0 0 0 4 (0.75) 4 (0.3) 0 * 0 0 0
Infiltrate 0 2 (0.1) 2 (0.1) 0 0 0 0 0 * 0 0 0
Adhesion 0 0 0 0 0 4 (0.2) 0 0 * 0 0 0
Inflammation 0 0 0 2.5 (0.6) 0 4 (0.75) 3.5 (0.7) 0 * 3 (1) 0 0
PP
Microcolony 0 0 0 3 (0.2) 0 0 0 0 * 0 0 0
Microabscess 0 0 1.5 (0.5) 0 0 0 0 0 * 0 0 0
Inflammation 2.5 (0.5) 2 (0.2) 0 0 0 2.8 (1) 2.5 (1) 0 * 2 (0.5) 0 0
Edema 0 0 2 (0.2) 0 2 (0.2) 3.8 (1) 2.5 (1) 0 * 2 (0.3) 0 0
Infiltrate 0 0 0 0 0 3 (0.75) 2 (1) 0 * 0 0 0
a Microcolony refers to a defined infiltrate with microscopic evidence of bacterial colonization.
b Microabscess refers to a defined infiltrate without evidence of bacterial colonization.
c Infiltrate refers to a small defined infiltration of PMNs that is distinct from a microabscess or microcolony based upon size and organization of the lesion.
d Inflammation is scored as an undefined congestion of PMNs and macrophages in the tissues; this is distinct from the defined lesions that constitute a microabscess,
microcolony, or infiltrate.
e An asterisk denotes that an insufficient number of animals survived to evaluate. Examples are shown in Fig. 2. Average pathological scores are reported from tissues
that had pathology and the frequency that the finding was observed relative to the total number of animals in the experimental group is reported as a fraction in the
parentheses (i.e., 1  100%).
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tive of a strong inflammatory response. This finding was in
contrast to the pathologies observed in mice infected orally
with the rovA mutant for 24 days. Mice infected orally for 24
days even with 109 CFU of the rovA mutant showed very
little evidence of inflammatory pathologies (data not
shown).
Not only were there significant inflammatory pathologies
apparent in the tissues of the mice infected i.p. for 24 days with
the rovA mutant, but there was evidence of disseminated bac-
terial infection. These findings range from minor findings such
as splenomeglia and small inflammatory infiltrates to very se-
vere findings such as fibrin thrombi, necrosis, and eschars (data
not shown and Fig. 2 and 3). Taken together, the data pre-
sented here suggest that the rovA mutant is capable of causing
severe disease in the mouse model of infection if the natural
route of infection is bypassed.
DISCUSSION
Y. enterocolitica has been an invaluable tool for understand-
ing the intricate interactions that occur between a bacterial
pathogen and the mammalian host. The reason that the system
is so powerful is multifactorial: (i) the bacteria and the mouse
are genetically tractable; (ii) the disease that is caused in the
mouse is similar to that caused in humans; and (iii) the patho-
gen can be delivered to the host by the natural route of infec-
tion (orally). By using this system, significant progress has been
made in the understanding of the host-pathogen interaction
(for reviews, see references 7, 10, 11, and 25). We now have a
greater understanding of bacterial factors important for the
invasion of host tissues, as well as of the molecules responsible
for the regulation of these factors. Examination of the mouse
as a model host also has provided insight into the T-cell,
TABLE 2. Histopathology of WT Y. enterocolitica-infected mice
Source
Avg pathological score (frequency [%]) of mice infected with WT Y. enteracolitica:
Orally at (day, dose
[CFU], no. of mice): i.p. at (day, dose [CFU], no. of mice):
14, 107, 5 24, 107, 5 1, 105, 5 3, 105, 5 5, 105, 5 14, 103, 5
24
102, 4 103, 3 104, 4 105, 4 106, 1 107, 1
Liver
Granuloma 4 (0.2) 0 0 0 4 (0.2) 3.5 (0.8) 0 0 0 0 *e *
Microcolonya 3 (0.2) 0 0 4 (0.2) 3.5 (0.6) 4 (0.8) 0 0 0 0 * *
Microabscessb 3 (0.2) 4 (0.8) 0 4 (0.2) 3.8 (0.8) 4 (0.8) 3 (0.3) 0 0 0 * *
Necrosis 2.8 (0.8) 3.5 (0.8) 0 0 3.2 (0.8) 3 (0.8) 3 (0.3) 0 0 2 (0.5) * *
Infiltratec 4 (0.4) 3 (0.8) 2 (0.2) 3 (0.6) 0 3.5 (1) 4 (0.3) 0 3 (0.5) 2.5 (1) * *
Fibrin thrombi 3 (0.4) 3.2 (0.6) 0 3 (0.2) 2 (0.2) 3 (0.4) 3 (0.3) 0 0 0 * *
Adhesion 0 0 0 0 0 4 (0.8) 0 0 0 0 * *
Spleen
Splenomegaly 3.2 (1) 4 (1) 0 0 0 3.8 (1) 4 (1) 4 (1) 4 (1) 4 (1) * *
Granuloma 4 (0.2) 0 0 3 (0.6) 4 (0.6) 3 (0.2) 0 0 0 0 * *
Microcolony 4 (0.2) 0 0 4 (0.6) 4 (0.6) 3.2 (1) 0 0 0 0 * *
Microabscess 4 (0.2) 0 2 (0.2) 4 (0.6) 4 (0.6) 3.2 (1) 3 (0.3) 0 3 (0.3) 0 * *
Necrosis 4 (0.2) 0 0 0 0 0 3 (0.3) 0 3 (0.3) 0 * *
Infiltrate 4 (0.2) 0 2 (0.2) 3 (0.6) 4 (0.6) 4 (1) 0 0 3 (0.3) 0 * *
Fibrin thrombi 4 (0.2) 0 0 0 0 0 0 0 0 0 * *
Adhesion 0 0 0 0 0 0 0 0 0 0 * *
Inflammationd 2.5 (0.5) 3.8 (0.8) 2 (0.2) 3 (0.6) 4 (0.6) 3.5 (1) 3 (0.3) 0 3 (0.3) 4 (0.3) * *
Mesenteric lymph
nodes
Granuloma 3 (0.8) 4 (0.4) 0 0 3 (0.2) 3.8 (1) 4 (0.5) 0 0 4 (1) * *
Microcolony 3.5 (0.8) 4 (0.4) 0 3 (0.2) 3 (0.6) 4 (1) 4 (0.5) 0 0 4 (1) * *
Microabscess 3 (0.8) 4 (0.4) 0 3 (0.2) 3 (0.2) 4 (0.6) 4 (0.5) 0 0 4 (1) * *
Necrosis 3 (0.8) 4 (0.4) 0 0 0 4 (0.2) 3.2 (0.8) 0 0 4 (0.5) * *
Infiltrate 2.5 (0.2) 0 0 3 (0.6) 3 (0.6) 4 (0.2) 3 (0.8) 0 0 4 (1) * *
Adhesion 0 0 0 0 0 3 (0.6) 0 0 0 4 (0.5) * *
Inflammation 3.5 (1) 3.8 (1) 2 (0.2) 3 (0.6) 3 (0.6) 3.8 (1) 4 (1) 0 0 3.5 (1) * *
PP
Microcolony 4 (0.2) 0 0 3.8 (0.8) 3.8 (0.8) 4 (0.2) 0 0 0 0 * *
Microabscess 4 (0.2) 0 0 3 (0.6) 0 0 0 0 0 0 * *
Inflammation 3 (0.6) 3 (1) 0 3 (0.6) 3 (0.8) 2 (1) 0 0 0 0 * *
Edema 3.8 (0.8) 3 (0.8) 0 0 0 2 (1) 0 0 0 0 * *
Infiltrate 3 (0.6) 3 (1) 0 3 (0.8) 3.8 (0.8) 0 0 0 0 0 * *
a See Table 1, footnote a.
b See Table 1, footnote b.
c See Table 1, footnote c.
d See Table 1, footnote d.
e See Table 1, footnote e.
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cytokine, and inflammatory responses to Y. enterocolitica in-
fection (1, 3–5, 12).
Recently, we took advantage of this system to identify the
regulator (rovA) of the principal invasion factor (inv) (14, 18,
24). Analysis of the rovA mutant in the mouse revealed an
attenuated phenotype, as well as a defect in the ability to cause
inflammation of the PP (12, 24). The defect in the ability to
cause PP inflammation was linked to a defect in the ability of
the host to induce IL-1 upon infection with the rovA mutant
(12, 24). The phenotypes observed during the initial charac-
terization of the rovA mutant in vivo utilized the natural route
of infection (oral). Because RovA was identified as a regulator
of inv and infection with the rovA mutant also affected the
inflammatory responses in the PP (which are not linked to inv),
it was reasonable to assume that RovA regulates gene products
that are important for host-pathogen interactions that occur in
the gut.
To further evaluate the role of rovA in the host-pathogen
interaction, we bypassed the PP and delivered the bacteria
directly into the peritoneum. Surprisingly, when mice are in-
fected i.p. with the rovA mutant, the bacteria are significantly
more virulent than when they are delivered by the oral route of
infection. During an oral infection the rovA mutant is 500-
fold attenuated by LD50 analysis, but during an i.p. infection
FIG. 2. Inflammatory histopathology of mice infected i.p. with the rovA mutant. (A) Normal mouse small intestine at 38 magnification. “L”
indicates the luminal surface, and “S” indicates the serosal surface. (B) Small intestine of a mouse infected for 5 days with 103 CFU of the rovA
mutant at 38 magnification. SC, serosal colony (a colony on the serosal surface of the small intestine). (C) Immunohistochemistry of the same
tissue shown in panel B). Ye, positive Y. enterocolitica immunoreactivity. (D) Normal mouse liver at 38 magnification. (E) Small infiltrate of the
liver of a mouse infected i.p. for 14 days with 102 CFU of the rovA mutant at 380 magnification. (F) Liver of a mouse infected i.p. for 14 days
with 102 CFU of the rovA mutant at 190 magnification. “N” indicates necrosis, and “MA” indicates microabscess (a large infiltrate without
microscopic evidence of bacterial colonization). (G) Liver of a mouse infected i.p. for 24 days with 102 CFU of the rovA mutant at 190
magnification. MC, microcolony (a large infiltrate with microscopic evidence of bacterial colonization). (H) Immunohistochemistry of the same
tissue shown in panel G at 380 magnification. Ye, positive Y. enterocolitica immunoreactivity. (I) Liver and kidney of a mouse infected for 24 days
with 103 CFU of the rovA mutant at 38 magnification. K,G, kidney granuloma; Li,G, liver granuloma; A, adhesion.
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the rovA mutant is 11-fold attenuated. This suggests that rovA
plays a critical role in the part of the bacterial life cycle that
occurs in the PP. Consistent with the data obtained from the
analysis of the kinetics of an oral rovA infection, there appears
to be a slight delay in the ability of the rovA mutant to colonize
the tissues of the peritoneum efficiently. This may be due to a
survival defect. The closely related rovA homolog (78% iden-
tical) from Salmonella (slyA) is sensitive to oxidative stress (8,
17). Although this has never been formally demonstrated for
the rovA mutant of Y. enterocolitica, the delay in the coloniza-
FIG. 3. i.p. infection with the rovA mutant induces an inflammatory response. C57BL/6j mice were infected i.p. for 14 days with 103 CFU of
either the rovA mutant or WT Y. enterocolitica. Livers were removed and prepared for immunohistochemistry of fresh frozen sections. All images
are either from the edge of the same large granuloma (A and B) or from the center of the granuloma (C) from the respective experimental group.
(A) Y. enterocolitica immunoreactivity is in green, and the macrophage-specific F4/80 antigen is in red; merged images are counterstained with
Hoechst dye. (B) Y. enterocolitica immunoreactivity is in green, and the  chain of the T-cell receptor is in red; merged images are counterstained
with Hoechst dye. (C) Y. enterocolitica immunoreactivity is in green, and the granulocyte-specific GR-1 antigen is in red; merged images are not
counterstained with Hoechst dye in this image to facilitate visualization of both markers. In all panels arrows indicate positive immunoreactivity.
All images are a magnification of 190.
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tion of the tissues of the peritoneum during an i.p. infection,
along with the attenuation phenotype observed during LD50
analysis, is consistent with a partial survival defect.
The most striking defect of the rovA mutant during an oral
infection is a lack of inflammation in the PP. The initial exam-
ination of this phenotype was limited to a 7-day time course. In
the present study we extended the histological analysis of the
oral rovA infection to 24 days. Consistent with our previous
results there appears to be very little inflammation of the PP
even after 14 or 24 days when mice are infected orally with the
rovA mutant. Interestingly, mice infected with the WT bacteria
are resolving the inflammatory pathologies of the gut at these
time points but still have significant pathologies in other tis-
sues. However, when mice are infected i.p. with the rovA mu-
tant, inflammatory pathologies can be observed as early as day
1 and consistently by day 5. Consistent with the kinetic data
there does appear to be a delay in the severity of the inflam-
matory pathologies observed in the rovA mutant-infected mice.
At the 24-day time point very severe inflammatory pathologies
can still be observed in the tissues from mice infected i.p. with
the rovA mutant. The presence of granulomas and adhesions in
the tissues of the mice infected i.p. with the rovA mutant for 24
days is indicative of a strong gamma interferon response. This
finding suggests that when the intestine is bypassed, the rovA
mutant is capable of initiating a strong inflammatory response.
Furthermore, these data suggest that the host response in the
gut and peritoneum may be different in significant ways that
influence the outcome of the infection. Interestingly, when
tissues from the day 24 rovA mutant and WT i.p. infections are
stained with a Y. enterocolitica specific antibody, the bacteria
are only apparent inside of the granulomas. This suggests that
granuloma integrity may help protect the infected mice from
the greater mortality and disease.
Altogether, the data presented in this report provides fur-
ther evidence for the possible role of the virulence factor RovA
during a Y. enterocolitica infection. One possible interpretation
of the data, although not the only one, is that RovA regulates
several sets of genes. One set of genes is involved in the
immediate-early stages of infection and is responsible for the
virulence phenotypes that are observed in the PP. These genes
would include inv and other genes that are responsible for
immediate events postinvasion of the PP, as well as genes
involved in the initiation of PP inflammation. A second set of
genes would be a set of genes that are expressed constitutively.
These genes may be responsible for helping with survival in the
host and thus play a role in both oral and i.p. infections. An
example would be genes responsible for protecting the bacteria
from oxidative stress. Any survival defect rovA has would only
be a partial defect because viable bacteria can be recovered
from the host after both an oral infection and an i.p. infection.
The differential virulence that the rovA mutant displays during
an oral infection versus an i.p. infection has further illustrated
the importance of RovA and the RovA-regulated genes during
the natural course of a Y. enterocolitica infection.
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